Vanguard Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8M | Buy |
1,290,994
+91,532
| +8% | +$2.68M | ﹤0.01% | 2251 |
|
|
2025
Q1 | $30.8M | Buy |
1,199,462
+21,015
| +2% | +$540K | ﹤0.01% | 2305 |
|
|
2024
Q4 | $34M | Buy |
1,178,447
+59,630
| +5% | +$1.72M | ﹤0.01% | 2326 |
|
|
2024
Q3 | $26.6M | Buy |
1,118,817
+162,510
| +17% | +$3.86M | ﹤0.01% | 2457 |
|
|
2024
Q2 | $16.5M | Buy |
956,307
+749,355
| +362% | +$13M | ﹤0.01% | 2655 |
|
|
2024
Q1 | $4.62M | Buy |
206,952
+3,241
| +2% | +$72.4K | ﹤0.01% | 3330 |
|
|
2023
Q4 | $3.74M | Buy |
203,711
+5,930
| +3% | +$109K | ﹤0.01% | 3394 |
|
|
2023
Q3 | $3.43M | Buy |
197,781
+689
| +0.3% | +$12K | ﹤0.01% | 3405 |
|
|
2023
Q2 | $3.59M | Buy |
197,092
+20,744
| +12% | +$378K | ﹤0.01% | 3458 |
|
|
2023
Q1 | $3.02M | Buy |
176,348
+1,074
| +0.6% | +$18.4K | ﹤0.01% | 3524 |
|
|
2022
Q4 | $4.07M | Buy |
175,274
+3,805
| +2% | +$88.4K | ﹤0.01% | 3397 |
|
|
2022
Q3 | $3.81M | Buy |
171,469
+19,482
| +13% | +$432K | ﹤0.01% | 3462 |
|
|
2022
Q2 | $2.93M | Sell |
151,987
-19,835
| -12% | -$382K | ﹤0.01% | 3640 |
|
|
2022
Q1 | $6.14M | Buy |
171,822
+71,769
| +72% | +$2.56M | ﹤0.01% | 3426 |
|
|
2021
Q4 | $8.71M | Buy |
100,053
+563
| +0.6% | +$49K | ﹤0.01% | 3296 |
|
|
2021
Q3 | $11.4M | Buy |
99,490
+95,204
| +2,221% | +$10.9M | ﹤0.01% | 3161 |
|
|
2021
Q2 | $921K | Buy |
+4,286
| New | +$921K | ﹤0.01% | 4167 |
|